Science news, opinion, interviews and product reports for scientists across all disciplines. Make Scientist Live my homepage  SciLive on Twitter21st November 2009

BookMark


Search

 

Readers Poll


Yes
No
Undecided


View Results »

Subscribe

Subscribe to Scientist Live

Click here for FREE subscription to eLab and eFood magazines

 

Newsletter

RSS Feed

Get the Scientist Live RSS Feed
RSS Feed

Visit our Products and Services Section


ITCM is a global manufacturer and leading innovator in customised machinery and systems for pharmaceutical packaging and processing.
eLab 2009-5-15 Issue

 View online magazine
 
 


eFood 2009-10-01 Issue

 View online magazine
 

eLab - Medical

Dangerous skin cancer

The German Cancer Society has worked out new guidelines for the diagnosis and treatment of malignant melanoma-a disease with unfavorable prognosis. Malignant melanoma is responsible for 90% of deaths from skin cancer. The incidence has increased 5-fold within the last 30 years and UV radiation is thought to be an important cause. Caucasian populations are most affected.

Claus Garbe of Tübingen University and his coauthors present the therapy of melanoma in the current edition of Deutsches Ärzteblatt International (Dtsch Arztebl Int 2008; 105[49]: 845-51). Physicians should confirm the diagnosis by histopathology after complete surgical removal of the tumour. The German Cancer Society recommends specific treatments or therapeutic combinations, depending on the thickness of the tumour and its stage. For example, if the tumour has more than a specific thickness, it is recommended that the primary tumour should be surgically removed, together with the sentinel lymph nodes and in combination with immunotherapy. If surgical removal is not possible, radiotherapy is indicated. If there are distant metastases, physicians should perform monochemotherapy.

 

©2008 Setform Limited

Site By OWB